The ACA of 2010 has provisions to allow the development of generic-like versions of biologics.

Name: The ACA of 2010 has provisions to allow the development of generic-like versions of biologics.
Brand: Quizplus
Rating: 4.8 (44 reviews)

Question

Quizplus · Accepted Answer

The ACA of 2010 included provisions for creating an abbreviated approval pathway for biosimilar and interchangeable biological products. These are similar to generic drugs in that they are intended to be lower-cost alternatives to their reference products, which are the originator biologics.

The ACA of 2010 Has Provisions to Allow the Development